SELECTIVE JAK2 INHIBITORS AND THEIR USES
AR135548A1Pending Publication Date: 2026-09-30V6 THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100772
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-08
- Filing Date
- 2025-03-25
- Publication Date
- 2026-09-30
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
This document describes compounds that are JAK2 inhibitors, methods for preparing such compounds, pharmaceutical compositions and medicinal products containing such compounds, and methods for using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of JAK2 activity. A compound of formula (1). A pharmaceutical composition comprising the compound according to any one of claims 1-72, or one of its pharmaceutically acceptable salts, N-oxides, tautomers, or solvates, and a pharmaceutically acceptable excipient.